Literature DB >> 16530867

The role of extracellular signal-regulated kinases in the neuroprotection of limb ischemic preconditioning.

Rui-Li Jin1, Wen-Bin Li, Qing-Jun Li, Min Zhang, Xiao-Hui Xian, Xiao-Cai Sun, Hong-Gang Zhao, Jie Qi.   

Abstract

To clarify the role of phosphorylated extracellular signal-regulated kinases (pERK1/2) in the neuroprotection of limb ischemic preconditioning (LIP) in rats, we investigated the expression of pERK1/2 using Western blot and flow cytometry in the hippocampus after LIP and the effect of pERK1/2 inhibitor PD 98059 on the neuroprotection of LIP against delayed neuronal death (DND) in the CA1 hippocampus normally induced by severe ischemic insult. It demonstrated that pERK1/2 in the hippocampus increased after LIP. In the CA1 hippocampus, ERK1/2 activation began to increase at 6h and reached peak at 12h after LIP, and decreased to sham level at 5d after LIP. On the other hand, in the CA3/DG, pERK1/2 enhanced at 1d, reached peak at 3d, and lasted to 5d after LIP. Pretreatment with PD 98059 before LIP blocked the neuroprotection of LIP in a dose-dependent manner. These findings supported that the upregulation of pERK1/2 in the CA1 hippocampus contributed to the neuroprotection of LIP against DND normally caused by the brain ischemic insult.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530867     DOI: 10.1016/j.neures.2006.01.006

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  17 in total

1.  Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway.

Authors:  Yilin Zhou; Nancy Fathali; Tim Lekic; Robert P Ostrowski; Chunhua Chen; Robert D Martin; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2010-12-23       Impact factor: 7.914

2.  The Protective Effects of Ischemic Postconditioning against Stroke: From Rapid to Delayed and Remote Postconditioning.

Authors:  Heng Zhao
Journal:  Open Drug Discov J       Date:  2011-12-24

Review 3.  From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia.

Authors:  Heng Zhao; Chuancheng Ren; Xingmiao Chen; Jiangang Shen
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

4.  Limb Remote Ischemic Preconditioning Reduces Repeated Ketamine Exposure-Induced Adverse Effects in the Developing Brain of Rats.

Authors:  Ying Liu; An Qi Li; Wan Ma; Yu Bo Gao; Li Qin Deng; Chun Zhang; Jin Hai Meng
Journal:  J Mol Neurosci       Date:  2019-03-07       Impact factor: 3.444

5.  Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.

Authors:  Miriam Fishbein; Sahar Gov; Fadi Assaf; Mikhal Gafni; Ora Keren; Yosef Sarne
Journal:  Exp Brain Res       Date:  2012-07-22       Impact factor: 1.972

6.  Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility.

Authors:  Sebastian Koch; Michael Katsnelson; Chuanhui Dong; Miguel Perez-Pinzon
Journal:  Stroke       Date:  2011-03-17       Impact factor: 7.914

7.  Preconditioning the human brain: practical considerations for proving cerebral protection.

Authors:  Sebastian Koch
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

8.  Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning.

Authors:  C Ren; X Gao; G K Steinberg; H Zhao
Journal:  Neuroscience       Date:  2007-12-15       Impact factor: 3.590

9.  Limb remote ischemic postconditioning protects against focal ischemia in rats.

Authors:  Chuancheng Ren; Zhimin Yan; Dingtai Wei; Xuwen Gao; Xiaoyuan Chen; Heng Zhao
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

10.  Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk.

Authors:  Quan-Guang Zhang; Rui-Min Wang; Dong Han; Li-Cai Yang; Jie Li; Darrell W Brann
Journal:  Neurosci Res       Date:  2009-03       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.